Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 p53 and chemosensitivity.

Literature DB >> 8612210

p53 and chemosensitivity.

G S Wu, W S El-Diery.

Abstract

Entities: Gene

Mesh：

Substances：
Paclitaxel

Year: 1996 PMID： 8612210 DOI： 10.1038/nm0396-255a

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

Keyword Cloud
Cited

× No keyword cloud information.

24 in total

Review 1. Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.

Authors: R J Michalides
Journal: J Clin Pathol Date: 1999-08 Impact factor: 3.411

2. p53-independent apoptosis induced by paclitaxel through an indirect mechanism.

Authors: J S Lanni; S W Lowe; E J Licitra; J O Liu; T Jacks
Journal: Proc Natl Acad Sci U S A Date: 1997-09-02 Impact factor: 11.205

3. p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity.

Authors: P Röhlke; K Milde-Langosch; C Weyland; U Pichlmeier; W Jonat; T Löning
Journal: J Cancer Res Clin Oncol Date: 1997 Impact factor: 4.553

4. The tubulysin analogue KEMTUB10 induces apoptosis in breast cancer cells via p53, Bim and Bcl-2.

Authors: Oluwafunmilayo F Lamidi; Monica Sani; Paolo Lazzari; Matteo Zanda; Ian N Fleming
Journal: J Cancer Res Clin Oncol Date: 2015-01-30 Impact factor: 4.553

5. Regulation of p53 expression by thymidylate synthase.

Authors: J Ju; J Pedersen-Lane; F Maley; E Chu
Journal: Proc Natl Acad Sci U S A Date: 1999-03-30 Impact factor: 11.205

6. Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin in combination with photodynamic therapy.

Authors: C Compagnin; M Mognato; L Celotti; G Canti; G Palumbo; E Reddi
Journal: Cell Prolif Date: 2010-06 Impact factor: 6.831

p53 and chemosensitivity.

Review 1. Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.

2. p53-independent apoptosis induced by paclitaxel through an indirect mechanism.

3. p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity.

4. The tubulysin analogue KEMTUB10 induces apoptosis in breast cancer cells via p53, Bim and Bcl-2.

5. Regulation of p53 expression by thymidylate synthase.

6. Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin in combination with photodynamic therapy.

7. Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells.

Review 8. Role of prolonged mitotic checkpoint activation in the formation and treatment of cancer.

9. The p53 breast cancer tissue biomarker in Indian women.

Review 10. Clinical implication of p53 mutation in lung cancer.